Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Biosimilars lower costs but don't significantly improve access.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

JAK inhibitors show promise in treating difficult skin diseases.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Gefitinib can cause hair and eyebrow darkening.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Abrus precatorius has medicinal benefits but can be toxic.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Bortezomib chemotherapy can cause temporary skin rashes.

Brodalumab is more effective than ustekinumab for treating psoriasis.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.